Hydrocodone Bitartrate and Acetaminophen Tablets — Class II drug recall D-0276-2022
Terminated recall by Ascent Pharmaceuticals, Inc., reported 2021-12-15, distributed nationwide. Product Mix-up
| Recall number | D-0276-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ascent Pharmaceuticals, Inc., Central Islip, NY, United States |
| Recall initiated | 2021-11-19 |
| Classified | 2021-12-07 |
| Reported by FDA | 2021-12-15 |
| Terminated | 2023-12-06 |
| Distributed | Nationwide (US) |
| Quantity | 9,744 bottles |
| NDC | 31722-0996, 31722-0996-01, 31722-0996-05, 31722-0997, 31722-0997-01, 31722-0997-05 |
| Lot numbers | 21070817 |
| Expiration dates | 2023-06 |
Product
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY 11722, NDC 31722-997-01.
Reason for recall
Product Mix-up
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0276-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.